Ishita Drugs & Industries share news, announcements and annual reports
BSE: 524400Pharmaceuticals & BiotechnologySmall Cap
Ishita Drugs & Industries Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1994
Last close ₹73.30down ₹0.50 (0.68%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹73.80.
30 Oct: open ₹73.50, high ₹73.50, low ₹73.30
52-week range of traded prices to 30 Oct 2026
₹66.00Low, 13 Jan 2026₹90.85High, 29 Dec 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22 Cr4,064th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.03
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,350
Ishita Drugs & Industries share news and announcements
527 announcements, routine notices left out, newest first. Page 8 of 11.
Mar 2019
Feb 2019
1 Feb · Board meeting
Meeting on 12 Feb 2019: quarterly results
Jan 2019
21 Jan · Shareholding for the Period Ended December 31, 2018
Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click ....7 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2018
Nov 2018
14 Nov · Management
Oct 2018
17 Oct · Compliance Certificate For The Half Year Ended September,2018
17 Oct · Shareholding for the Period Ended September 30, 2018
Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click ....8 Oct · Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 03 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Sep 2018
29 Sep · Meeting
Aug 2018
Jul 2018
21 Jul · Shareholding for the Period Ended June 30, 2018
Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click ....11 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
May 2018
Apr 2018
19 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....7 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2018
2 Feb · Intimation For Board Meeting For The Quarter Ended On December 31St, 2017.
Jan 2018
20 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....6 Jan · Statement Of Investor Complaints For The Quarter Ended On 31St December 2017.
Nov 2017